glp-1 agonist depression Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study Psychological and behavioral effects of

Due to a short plasma half-life of native GLP-1, several synthesized GLP-1 receptor agonists (RAs) were developed for type 2 diabetes mellitus (DM) treatment

Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity

There have been and continue to be advances in the GLP-1 pipeline.

Green Coffee Bean Extract has anti-inflammatory properties that may help increase basal metabolic rate and natural GLP-1 production

Emerging applications include non-alcoholic fatty liver disease and neurodegenerative conditions

Allulose is not a GLP-1 agonist, but emerging research suggests it may modulate glucose metabolism and GLP-1 secretion in ways that merit clinical attention